Dosage Forms < Dose-Response Relationship, Drug < Dose-Response Relationship, Immunologic

Facettes : AffPays.f Mesh.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 74.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000182 (2003)	T. Feldt [Allemagne] ; M. Oette ; A. Kroidl ; K. Göbels ; J. Richter ; D. H Ussinger	[SARS--the facts. Transmission, diagnosis and managing suspected cases].
000500 (2004)	Swee Kee Wong [États-Unis] ; Wenhui Li ; Michael J. Moore ; Hyeryun Choe ; Michael Farzan	A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2.
000825 (2004)	Jieqing Zhu [République populaire de Chine] ; Gengfu Xiao ; Yanhui Xu ; Fang Yuan ; Congyi Zheng ; Yueyong Liu ; Huimin Yan ; David K. Cole ; John I. Bell ; Zihe Rao ; Po Tien ; George F. Gao	Following the rule: formation of the 6-helix bundle of the fusion core from severe acute respiratory syndrome coronavirus spike protein and identification of potent peptide inhibitors.
000886 (2004)	Emily L. C. Tan [Singapour] ; Eng Eong Ooi [Singapour] ; Chin-Yo Lin [Singapour] ; Hwee Cheng Tan [Singapour] ; Ai Ee Ling [Singapour] ; Bing Lim [Singapour] ; Lawrence W. Stanton [Singapour]	Inhibition of SARS Coronavirus Infection In Vitro with Clinically Approved Antiviral Drugs
000945 (2004)	Runtao He [Canada] ; Anton Adonov [Canada] ; Maya Traykova-Adonova [Canada] ; Jingxin Cao [Canada] ; Todd Cutts [Canada] ; Elsie Grudesky [Canada] ; Yvon Deschambaul [Canada] ; Jody Berry [Canada] ; Michael Drebot [Canada] ; Xuguang Li [Canada]	Potent and selective inhibition of SARS coronavirus replication by aurintricarboxylic acid
000982 (2004)	Bojian Zheng [Hong Kong] ; Ming-Liang He ; King-Ling Wong ; Ching Tung Lum ; Leo L M. Poon ; Ying Peng ; Yi Guan ; Marie C M. Lin ; Hsiang-Fu Kung	Potent inhibition of SARS-associated coronavirus (SCOV) infection and replication by type I interferons (IFN-alpha/beta) but not by type II interferon (IFN-gamma).
000A52 (2004)	Els Keyaerts ; Leen Vijgen ; Piet Maes ; Johan Neyts ; Marc Van Ranst	In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine
000C10 (2005)	Yi Shi [République populaire de Chine] ; Haifeng Luo ; Jie Jia ; Jie Xiong ; Dehua Yang ; Bing Huang ; Youxin Jin	Antisense downregulation of SARS-CoV gene expression in Vero E6 cells.
000C66 (2004)	Birgit Morgenstern [Allemagne] ; Martin Michaelis [Allemagne] ; Patrick C. Baer [Allemagne] ; Hans W. Doerr [Allemagne] ; Jindrich Cinatl [Allemagne]	Ribavirin and interferon-β synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines
000E59 (2005)	Chuan-Hai Zhang [République populaire de Chine] ; Yi-Fei Wang ; Xin-Jian Liu ; Jia-Hai Lu ; Chui-Wen Qian ; Zhuo-Yue Wan ; Xin-Ge Yan ; Huan-Ying Zheng ; Mei-Ying Zhang ; Sheng Xiong ; Jiu-Xiang Li ; Shu-Yuan Qi	Antiviral activity of cepharanthine against severe acute respiratory syndrome coronavirus in vitro.
000E66 (2005)	Julian A. Tanner [République populaire de Chine] ; Bo-Jian Zheng ; Jie Zhou ; Rory M. Watt ; Jie-Qing Jiang ; Kin-Ling Wong ; Yong-Ping Lin ; Lin-Yu Lu ; Ming-Liang He ; Hsiang-Fu Kung ; Andreas J. Kesel ; Jian-Dong Huang	The adamantane-derived bananins are potent inhibitors of the helicase activities and replication of SARS coronavirus.
000F76 (2005)	Bo-Jion Zheng [République populaire de Chine] ; Yi Guan ; Ming-Liang Hez ; Hongzhe Sun ; Lanying Du ; Ying Zheng ; Kin-Ling Wong ; Honglin Chen ; Ying Chen ; Linyu Lu ; Julian A. Tanner ; Rory M. Watt ; Neri Niccolai ; Andrea Bernini ; Ottavia Spiga ; Patrick C Y. Woo ; Hsiang-Fu Kung ; Kwok-Yung Yuen ; Jian-Dong Huang	Synthetic peptides outside the spike protein heptad repeat regions as potent inhibitors of SARS-associated coronavirus.
001000 (2005)	Lixin Xie [République populaire de Chine] ; Youning Liu ; Yueyong Xiao ; Qing Tian ; Baoxing Fan ; Hong Zhao ; Weijun Chen	Follow-up study on pulmonary function and lung radiographic changes in rehabilitating severe acute respiratory syndrome patients after discharge.
001068 (2005)	Song-Le Zhang [République populaire de Chine] ; Li-Juan Ma ; Guang Tian ; Liang-Yan Zhang ; Xue-Ying Zhang ; Xi-Liang Wang	[Conditions for SARS-CoV cultivation and inactivation].
001071 (2005)	Shuetsu Fukushi [Japon] ; Tetsuya Mizutani [Japon] ; Masayuki Saijo [Japon] ; Shutoku Matsuyama [Japon] ; Naoko Miyajima [Japon] ; Fumihiro Taguchi [Japon] ; Shigeyuki Itamura [Japon] ; Ichiro Kurane [Japon] ; Shigeru Morikawa [Japon]	Vesicular stomatitis virus pseudotyped with severe acute respiratory syndrome coronavirus spike protein.
001129 (2005)	Bao-Jian Li [République populaire de Chine] ; Qingquan Tang ; Du Cheng ; Chuan Qin ; Frank Y. Xie ; Qiang Wei ; Jun Xu ; Yijia Liu ; Bo-Jian Zheng ; Martin C. Woodle ; Nanshan Zhong ; Patrick Y. Lu	Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque.
001151 (2005)	Xiliang Wang [République populaire de Chine] ; Bing Ni ; Xinan Du ; Guangyu Zhao ; Wenda Gao ; Xinfu Shi ; Songle Zhang ; Liangyan Zhang ; Dong Wang ; Deyan Luo ; Li Xing ; Haiyan Jiang ; Wanling Li ; Man Jiang ; Liwei Mao ; Yangdong He ; Yu Xiao ; Yuzhang Wu	Protection of mammalian cells from severe acute respiratory syndrome coronavirus infection by equine neutralizing antibody.
001347 (2006)	Milan Surjit [Inde] ; Boping Liu ; Vincent T K. Chow ; Sunil K. Lal	The nucleocapsid protein of severe acute respiratory syndrome-coronavirus inhibits the activity of cyclin-cyclin-dependent kinase complex and blocks S phase progression in mammalian cells.
001458 (2006)	Bruno Sainz [États-Unis] ; Eric C. Mossel [États-Unis] ; William R. Gallaher [États-Unis] ; William C. Wimley [États-Unis] ; C. J. Peters [États-Unis] ; Russell B. Wilson [États-Unis] ; Robert F. Garry [États-Unis]	Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein
001512 (2007)	Tin-Yun Ho [Taïwan] ; Shih-Lu Wu ; Jaw-Chyun Chen ; Chia-Cheng Li ; Chien-Yun Hsiang	Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction.
001587 (2006)	Anna De Lang [Pays-Bas] ; Albert D M E. Osterhaus ; Bart L. Haagmans	Interferon-gamma and interleukin-4 downregulate expression of the SARS coronavirus receptor ACE2 in Vero E6 cells.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Ncbi/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Dose-Response Relationship, Drug" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Dose-Response Relationship, Drug" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Dose-Response Relationship, Drug
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021